Medication info
Atorjet Tablets 10/20 Milligrams

Atorjet Tablets 10/20 Milligrams

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tabletAtorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Korea PMG Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/box[(10 tablets/PTP packaging (Alu-Alu) x 3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202101543 · Approved 2021.02.18 · Insurance code 697101030

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who uses it
Adults
Adult dosage
Administer this medication once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/10 mg to 10/80 mg once daily. The recommended initial dosage is 10/10 mg or 10/20 mg once daily. For patients requiring a greater reduction in LDL cholesterol (55 % or more), the recommended initial dosage is 10/40 mg once daily. After starting treatment or adjusting the dosage, check blood lipid levels at intervals of at least 2 weeks and adjust the dosage accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40 mg or 10/80 mg once daily. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.

Ingredients

Manufacturer
Korea PMG Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • elevated total cholesterol
  • LDL-cholesterol
  • Apo B protein
  • triglycerides
  • non-HDL-cholesterol increase
View approved original text

This drug is used as an adjunct to diet for the reduction of elevated total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and for the increase of HDL-cholesterol levels. It may also be used in patients with homozygous familial hypercholesterolemia either alone or together with other lipid-lowering therapies (e.g., LDL-Apheresis) when those treatments are not effective. It should be administered with appropriate dietary measures, including limitation of saturated fats and cholesterol, and any secondary causes of dyslipidemia should be investigated and treated. Since this drug has not established a clear benefit in reducing cardiovascular morbidity and mortality, it should be administered while considering the patient's risk factors. Lipid testing, including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides, is important, and in patients with an acute coronary event, lipid levels should be measured at admission or within 24 hours. Thus, this drug improves lipid levels in managing hypercholesterolemia and dyslipidemia.

Dosage and Administration

Adult dosage

Administer this medication once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/10 mg to 10/80 mg once daily. The recommended initial dosage is 10/10 mg or 10/20 mg once daily. For patients requiring a greater reduction in LDL cholesterol (55 % or more), the recommended initial dosage is 10/40 mg once daily. After starting treatment or adjusting the dosage, check blood lipid levels at intervals of at least 2 weeks and adjust the dosage accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40 mg or 10/80 mg once daily. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.

Precautions

This drug may rarely cause muscle damage, so if symptoms of severe muscle pain or muscle weakness occur, the doctor should be notified immediately. In patients at high risk for muscle damage, for example after severe infections, hypotension, major surgery, or trauma, the use of this drug should be temporarily stopped or discontinued. Patients allergic to any components of this drug, those with active liver disease or persistent unexplained increases in liver enzymes, or patients with muscle disorders should not use this drug. Women who are pregnant or may become pregnant, as well as nursing women, should not use this drug. Moreover, patients taking certain antiviral drugs or fibrate-class medications should not take this drug concurrently. Patients with a history of alcohol abuse or liver disease, those with severe liver dysfunction, or patients with kidney impairment or hypothyroidism should use this drug cautiously. This drug contains yellow pigment, so individuals with allergies to it should take care. Patients taking this drug should regularly undergo liver function tests, and if any symptoms of liver dysfunction (e.g., nausea, vomiting, fatigue, etc.) occur, they should consult a doctor immediately. This drug has many interactions with other medications, so if patients are taking other medications, they must inform their doctor or pharmacist, especially if combined with drugs that affect liver metabolism. While taking this drug, dizziness or muscle pain may occur, so caution should be exercised when driving or operating machinery. There are no specific antidotes for overdose, so patients should visit a medical institution immediately for appropriate treatment and monitoring. Safety and efficacy in children have not been established, so it is not recommended for use in this population. Elderly patients are at higher risk of muscle damage, so they should be observed carefully without dose adjustments. This drug should be kept out of the reach of children and should not be transferred to another container.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, increased liver enzymes, ALT increase, AST increase, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyp, duodenal polyp, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenails, thyroid adenoma, weakness, fatigue, chest pain, peripheral edema, fatigue, fever, nasopharyngitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal distension, indigestion, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, epistaxis, insomnia, nightmares, headache, paresthesia, sensory loss, taste disturbance, memory loss, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications due to rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reaction, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, increased serum creatine kinase, positive urinary leukocytes, nightmares, blurred vision, vomiting, abdominal abnormalities, hepatitis, cholestasis, cholestatic jaundice, abnormal liver function tests, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gingival bleeding, urgency, bronchitis, rhinitis, pneumonia, dyspnea, asthma, altered sensations, vertigo, photosensitivity reactions, drowsiness, forgetfulness, abnormal dreams, decreased libido, emotional instability, ataxia, torticollis, facial paralysis, hyperkinesia, tension dysregulation, arthritis, bursitis, tenosynovitis, myasthenia gravis, contractures, CK elevation, elevated serum myoglobin, itching, contact dermatitis, dry skin, sweating, acne, eczema, seborrhea, skin ulcers, erectile dysfunction, urinary tract infection, increased urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast hypertrophy, cervical discharge, nephritis, urinary incontinence, urinary retention, urinary urgency, abnormal ejaculation, uterine bleeding, pigmentation in urine, hypoglycemia, increased appetite, vasomotor edema, chest pain, angina, facial edema, fever, neck stiffness, generalized edema, amblyopia, dry eyes, refractive errors, eye hemorrhage, hearing loss, glaucoma, visual disturbances, taste loss, taste disorder, leukopenia, decreased testosterone, increased cholinesterase, increased TSH, increased ACTH, decreased aldosterone, elevated potassium, elevated BUN, cerebral infarction, palpitations, tachycardia, positive urinary leukocytes, anaphylaxis, urticaria, rash, angioedema, elevated creatine phosphokinase, myopathy, elevated liver aminotransferases, thrombocytopenia, nausea, dizziness, cholelithiasis, cholecystitis, drug-induced liver injury, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, erythema multiforme, fatigue, chest discomfort, edema, asthenia, generalized edema, diabetic neuropathy, tremors, upper abdominal pain, gastritis, epigastric discomfort, gastrointestinal disorders, gastroesophageal reflux disease, glossopathy, palpitations, congestive heart failure, myocardial ischemia, sputum, rhinorrhea, limb pain, diabetes, splenomegaly, hyperhidrosis, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased serum urea.

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/box[(10 tablets/PTP packaging (Alu-Alu) x 3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.